PT  - JOURNAL ARTICLE
AU  - Lamb, Matthew R.
AU  - Kandula, Sasikiran
AU  - Shaman, Jeffrey
TI  - Differential COVID-19 case positivity in New York City neighborhoods: socioeconomic factors and mobility
AID  - 10.1101/2020.07.01.20144188
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.01.20144188
4099  - http://medrxiv.org/content/early/2020/07/02/2020.07.01.20144188.short
4100  - http://medrxiv.org/content/early/2020/07/02/2020.07.01.20144188.full
AB  - New York City has been one of the hotspots of the COVID-19 pandemic and during the first two months of the outbreak considerable variability in case positivity was observed across the city’s ZIP codes. In this study, we examined: a) the extent to which the variability in ZIP code level cases can be explained by aggregate markers of socioeconomic status and daily change in mobility; and b) the extent to which daily change in mobility independently predicts case positivity.Our analysis indicates that the markers considered together explained 56% of the variability in case positivity through April 1 and their explanatory power decreased to 18% by April 30. Our analysis also indicates that changes in mobility during this time period are not likely to be acting as a mediator of the relationship between ZIP-level SES and case positivity. During the middle of April, increases in mobility were independently associated with decreased case positivity. Together, these findings present evidence that heterogeneity in COVID-19 case positivity during the New York City spring outbreak was largely driven by residents’ socioeconomic status.Competing Interest StatementJS and Columbia University disclose partial ownership of SK Analytics. JS discloses consulting for BNI.Funding StatementThis works was supported by funding from the National Institutes of Health (GM110748 to JLS and SK) and the National Science Foundation (DMS-2027369 to JLS and SK), as well as a gift from the Morris-Singer Foundation (JLS and SK). The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is an aggregate data analysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is publicly available data obtained from the following sources: https://github.com/nychealth/coronavirus-data https://www.census.gov/acs/www/data/data-tables-and-tools/data-profiles/2016/ In addition, data on mobility was obtained from the following source and is available for purchase: https://www.safegraph.com/